Agnes Lemarchand

Agnes Lemarchand is a declared insider at 2 companies (board member); the most frequent names are Biomerieux and Compagnie de Saint-Gobain. Between 9 December 2020 and 8 November 2022, the trades on record add up to 5 filings.

Market trades split into 3 purchases (€137k) and 2 sales (€43k). Netting one side against the other leaves €94k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2022, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €41k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month. After 3 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -27.5%. This is a record of the past, not a forecast.

The newest entry dates from 15 November 2022: an open-market purchase of €60k, in Compagnie de Saint-Gobain. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.